MedPath

MARKSANS PHARMA LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Pregabalin

Approval Date
Jun 10, 2025
FDA

Famotidine 20 mg

Approval Date
May 6, 2025
FDA

Duloxetine

Approval Date
Oct 5, 2023
FDA

Fluoxetine

Approval Date
Sep 26, 2023
FDA

Metformin Hydrochloride

Approval Date
Jun 23, 2022
FDA

Ibuprofen

Approval Date
Feb 17, 2022
FDA

GABAPENTIN

Approval Date
Sep 6, 2021
FDA

Naproxen

Approval Date
May 26, 2021
FDA

Metformin Hydrochloride

Approval Date
Nov 27, 2019
FDA

Paricalcitol

Approval Date
May 26, 2017
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

FDA Inspection of Emcure's API Facility Results in Form 483; Relonchem Gains UK Approval for Pain Relief Combination

Emcure Pharmaceuticals' API manufacturing facility in Maharashtra underwent a week-long USFDA cGMP inspection, resulting in two Form 483 observations.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.